Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diabetology & Metabolic Syndrome
Published in: Diabetology & Metabolic Syndrome 1/2019

Open Access 01-12-2019 | Obesity | Research

Zinc supplementation improves body weight management, inflammatory biomarkers and insulin resistance in individuals with obesity: a randomized, placebo-controlled, double-blind trial

Authors: Hoda Khorsandi, Omid Nikpayam, Reyhaneh Yousefi, Maryam Parandoosh, Nima Hosseinzadeh, Atoosa Saidpour, Arman Ghorbani

Published in: Diabetology & Metabolic Syndrome | Issue 1/2019

Login to get access

Abstract

Background

The present study was designed to determine whether zinc supplementation would increase the effects of restricted calorie diet (RCD) on obesity.

Methods and materials

A randomized, double-blind clinical trial was performed on 40 obese subjects who were randomly assigned to receive zinc supplements (30 mg/day) or placebo for a period of 15-weeks. Both groups were under a restricted calorie diet (~ 300 kcal lower than the estimated energy requirement). Anthropometric measurements, biochemical markers, appetite, and dietary intakes were determined during the study period.

Results

The reductions of body weight, body mass index, waist circumference, and hip circumference were significantly higher in the zinc group compared to the placebo group (P = 0.032, 0.025, 0.003, and 0.0001, respectively). Lower levels of high sensitivity C-reactive protein, apelin, homeostatic model assessment of insulin resistance (HOMA-IR), and appetite score were observed in the zinc group in comparison with the placebo group (P = 0.0001, 0.001, 0.031 and 0.001 respectively).

Conclusion

This study indicates that Zn supplementation with a restricted calorie diet has favorable effects in reducing anthropometric measurements, inflammatory markers, insulin resistance and appetite in individuals with obesity, and may play an effective role in the treatment of obesity.
Trial registration This clinical trial was registered at clinicaltrials.gov at the U.S. National Library of Medicine (NCT02516475).
Literature
1.
Gamboa-Gomez CI, Rocha-Guzman NE, Gallegos-Infante JA, Moreno-Jimenez MR, Vazquez-Cabral BD, Gonzalez-Laredo RF. Plants with potential use on obesity and its complications. EXCLI J. 2015;14:809–31.PubMedPubMedCentral
2.
Svetkey LP, Stevens VJ, Brantley PJ, Appel LJ, Hollis JF, Loria CM, et al. Comparison of strategies for sustaining weight loss: the weight loss maintenance randomized controlled trial. JAMA. 2008;299:1139–48.PubMedCrossRef
3.
Piehowski KE, Preston AG, Miller DL, Nickols-Richardson SM. A reduced-calorie dietary pattern including a daily sweet snack promotes body weight reduction and body composition improvements in premenopausal women who are overweight and obese: a pilot study. J Am Diet Assoc. 2011;111:1198–203.PubMedPubMedCentralCrossRef
4.
Most J, Tosti V, Redman LM, Fontana L. Calorie restriction in humans: an update. Ageing Res Rev. 2017;39:36–45.PubMedCrossRef
5.
Cheng HL, Griffin HJ, Bryant CE, Rooney KB, Steinbeck KS, O’Connor HT. Impact of diet and weight loss on iron and zinc status in overweight and obese young women. Asia Pac J Clin Nutr. 2013;22:574–82.PubMed
6.
Cheng HL, Bryant C, Cook R, O’Connor H, Rooney K, Steinbeck K. The relationship between obesity and hypoferraemia in adults: a systematic review. Obes Rev. 2012;13:150–61.PubMedCrossRef
7.
García OP, Ronquillo D, del Carmen Caamaño M, Martínez G, Camacho M, López V, et al. Zinc, iron and vitamins A, C and E are associated with obesity, inflammation, lipid profile and insulin resistance in Mexican school-aged children. Nutrients. 2013;5:5012–30.PubMedPubMedCentralCrossRef
8.
Farsani GM, Targhi FZ, Pishgahroudsari M, Mokhber S, Pazouki A. High prevalence of zinc deficiency in Iranian morbid obese patients undergoing bariatric surgery. J Minim Invasive Surg Sci. 2015;4:e33347.
9.
Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA. 2003;289:1799–804.PubMedCrossRef
10.
Ishikawa Y, Kudo H, Kagawa Y, Sakamoto S. Increased plasma levels of zinc in obese adult females on a weight-loss program based on a hypocaloric balanced diet. In Vivo. 2005;19:1035–7.PubMed
11.
Helen O, Munas Z, Griffin H, Rooney K, Cheng HL, Steinbeck K. Nutritional adequacy of energy restricted diets for young obese women. Asia Pac J Clin Nutr. 2011;20:206–11.
12.
13.
Kimmons JE, Blanck HM, Tohill BC, Zhang J, Khan LK. Associations between body mass index and the prevalence of low micronutrient levels among US adults. Med Gen Med. 2006;8:59.
14.
Marreiro DDN, Fisberg M, Cozzolino SMF. Zinc nutritional status in obese children and adolescents. Biol Trace Elem Res. 2002;86:107–22.PubMedCrossRef
15.
Kaidar-Person O, Person B, Szomstein S, Rosenthal RJ. Nutritional deficiencies in morbidly obese patients: a new form of malnutrition? Obes Surg. 2008;18:870–6.PubMedCrossRef
16.
Payahoo L, Ostadrahimi A, Mobasseri M, Bishak YK, Farrin N, Jafarabadi MA, et al. Effects of zinc supplementation on the anthropometric measurements, lipid profiles and fasting blood glucose in the healthy obese adults. Adv Pharm Bull. 2013;3:161.PubMedPubMedCentral
17.
do Nascimento Marreiro D, Geloneze B, Tambascia MA, Lerário AC, Halpern A, Cozzolino SMF. Effect of zinc supplementation on serum leptin levels and insulin resistance of obese women. Biol Trace Elem Res. 2006;112:109–18.CrossRef
18.
Cruz KJC, de Oliveira ARS, Morais JBS, Severo JS, Mendes PMV, de Sousa Melo SR, et al. Zinc and insulin resistance: biochemical and molecular aspects. Biol Trace Elem Res. 2018;186:407–12.PubMedCrossRef
19.
Haase H, Maret W. Protein tyrosine phosphatases as targets of the combined insulinomimetic effects of zinc and oxidants. Biometals. 2005;18:333–8.PubMedCrossRef
20.
Olechnowicz J, Tinkov A, Skalny A, Suliburska J. Zinc status is associated with inflammation, oxidative stress, lipid, and glucose metabolism. J Physiol Sci. 2017;68:19–31.PubMedPubMedCentralCrossRef
21.
Mantzoros CS, Prasad AS, Beck FW, Grabowski S, Kaplan J, Adair C, et al. Zinc may regulate serum leptin concentrations in humans. J Am Coll Nutr. 1998;17:270–5.PubMedCrossRef
22.
Bonaventura P, Benedetti G, Albarede F, Miossec P. Zinc and its role in immunity and inflammation. Autoimmun Rev. 2015;14:277–85.PubMedCrossRef
23.
Prasad AS. Zinc: role in immunity, oxidative stress and chronic inflammation. Curr Opin Clin Nutr Metab Care. 2009;12:646–52.PubMedCrossRef
24.
Foster M, Petocz P, Samman S. Inflammation markers predict zinc transporter gene expression in women with type 2 diabetes mellitus. J Nutr Biochem. 2013;24:1655–61.PubMedCrossRef
25.
26.
Lago F, Dieguez C, Gomez-Reino J, Gualillo O. Adipokines as emerging mediators of immune response and inflammation. Nat Clin Pract Rheumatol. 2007;3:716–24.PubMedCrossRef
27.
28.
Krist J, Wieder K, Klöting N, Oberbach A, Kralisch S, Wiesner T, et al. Effects of weight loss and exercise on apelin serum concentrations and adipose tissue expression in human obesity. Obes Facts. 2013;6:57–69.PubMedPubMedCentralCrossRef
29.
García OP, Long KZ, Rosado JL. Impact of micronutrient deficiencies on obesity. Nutr Rev. 2009;67:559–72.PubMedCrossRef
30.
Kim J, Ahn J. Effect of zinc supplementation on inflammatory markers and adipokines in young obese women. Biol Trace Elem Res. 2014;157:101–6.PubMedCrossRef
31.
Maret W, Sandstead HH. Zinc requirements and the risks and benefits of zinc supplementation. J Trace Elem Med Biol. 2006;20:3–18.PubMedCrossRef
32.
Prasad AS. Impact of the discovery of human zinc deficiency on health. J Am Coll Nutr. 2009;28:257–65.PubMedCrossRef
33.
Mahan LK, Raymond JL, Escott-Stump S. Krause’s food & the nutrition care process-E-Book. St. Louis: Elsevier Health Sciences; 2013.
34.
Mifflin MD, St Jeor ST, Hill LA, Scott BJ, Daugherty SA, Koh YO. A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr. 1990;51:241–7.PubMedCrossRef
35.
Goldberg G, Black A, Jebb S, Cole T, Murgatroyd P, Coward W, et al. Critical evaluation of energy intake data using fundamental principles of energy physiology: 1. Derivation of cut-off limits to identify under-recording. Eur J Clin Nutr. 1991;45:569–81.PubMed
36.
Wilson MM, Thomas DR, Rubenstein LZ, Chibnall JT, Anderson S, Baxi A, et al. Appetite assessment: simple appetite questionnaire predicts weight loss in community-dwelling adults and nursing home residents. Am J Clin Nutr. 2005;82:1074–81.CrossRefPubMed
37.
Mahan LK, EHammond K. Dietary and clinical assessment. Krause’s food and nutrition therapy; 2000, p. 372.
38.
Aadahl M, JØrgensen T. Validation of a new self-report instrument for measuring physical activity. Med Sci Sports Exerc. 2003;35:1196–202.PubMedCrossRef
39.
40.
Bishop ML, Fody EP, Schoeff LE. Clinical chemistry: principles, techniques, and correlations. Philadelphia: Lippincott Williams & Wilkins; 2013.
41.
Smith J, Butrimovitz G, Purdy W. Direct measurement of zinc in plasma by atomic absorption spectroscopy. Clin Chem. 1979;25:1487–91.PubMed
42.
Chong PW, Beah ZM, Grube B, Riede L. IQP-GC-101 reduces body weight and body fat mass: a randomized, double-blind, placebo-controlled study. Phytother Res. 2014;28:1520–6.PubMedPubMedCentralCrossRef
43.
Jing M-Y, Sun J-Y, Weng X-Y. Insights on zinc regulation of food intake and macronutrient selection. Biol Trace Elem Res. 2007;115:187–94.PubMedCrossRef
44.
Costarelli L, Muti E, Malavolta M, Cipriano C, Giacconi R, Tesei S, et al. Distinctive modulation of inflammatory and metabolic parameters in relation to zinc nutritional status in adult overweight/obese subjects. J Nutr Biochem. 2010;21:432–7.PubMedCrossRef
45.
46.
Lee RG, Rains TM, Tovar-Palacio C, Beverly JL, Shay NF. Zinc deficiency increases hypothalamic neuropeptide Y and neuropeptide Y mRNA levels and does not block neuropeptide Y-induced feeding in rats. J Nutr. 1998;128:1218–23.PubMedCrossRef
47.
Selvais PL, Labuche C, Ninh NX, Ketelslegers JM, Denef JF, Maiter DM. Cyclic feeding behaviour and changes in hypothalamic galanin and neuropeptide Y gene expression induced by zinc deficiency in the rat. J Neuroendocrinol. 1997;9:55–62.PubMedCrossRef
48.
Johnson S. Micronutrient accumulation and depletion in schizophrenia, epilepsy, autism and Parkinson’s disease? Med Hypotheses. 2001;56:641–5.PubMedCrossRef
49.
Baltaci AK, Mogulkoc R, Kul A, Bediz CS, Ugur A. Opposite effects of zinc and melatonin on thyroid hormones in rats. Toxicology. 2004;195:69–75.PubMedCrossRef
50.
Robertson R, Zhou H, Slucca M. A role for zinc in pancreatic islet β-cell cross-talk with the α-cell during hypoglycaemia. Diabetes Obes Metab. 2011;13:106–11.PubMedCrossRef
51.
Mashhadi MA, Bakhshipour A, Zakeri Z, Ansari-Moghadam A. Reference range for zinc level in young healthy population in southeast of Iran. Health Scope. 2017;6:e18181.
52.
Welch CC, Grace MK, Billington CJ, Levine AS. Preference and diet type affect macronutrient selection after morphine, NPY, norepinephrine, and deprivation. Am J Physiol. 1994;266:R426–33.PubMed
53.
Lago F, Dieguez C, Gómez-Reino J, Gualillo O. Adipokines as emerging mediators of immune response and inflammation. Nat Rev Rheumatol. 2007;3:716.CrossRef
54.
55.
Selvin E, Paynter NP, Erlinger TP. The effect of weight loss on C-reactive protein: a systematic review. Arch Intern Med. 2007;167:31–9.PubMedCrossRef
56.
Heinonen M, Laaksonen D, Karhu T, Karhunen L, Laitinen T, Kainulainen S, et al. Effect of diet-induced weight loss on plasma apelin and cytokine levels in individuals with the metabolic syndrome. Nutr Metab Cardiovasc Dis. 2009;19:626–33.PubMedCrossRef
57.
58.
Straznicky NE, Lambert EA, Grima MT, Eikelis N, Richards K, Nestel PJ, et al. The effects of dietary weight loss on indices of norepinephrine turnover: modulatory influence of hyperinsulinemia. Obesity (Silver Spring, Md). 2014;22:652–62.CrossRef
59.
Weiss EP, Albert SG, Reeds DN, Kress KS, Ezekiel UR, McDaniel JL, et al. Calorie Restriction and Matched Weight Loss From Exercise: independent and Additive Effects on Glucoregulation and the Incretin System in Overweight Women and Men. Diabetes Care. 2015;38:1253–62.PubMedPubMedCentralCrossRef
60.
Weiss EP, Racette SB, Villareal DT, Fontana L, Steger-May K, Schechtman KB, et al. Improvements in glucose tolerance and insulin action induced by increasing energy expenditure or decreasing energy intake: a randomized controlled trial. Am J Clin Nutr. 2006;84:1033–42.PubMedCrossRef
61.
Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50.CrossRefPubMed
62.
63.
Kelishadi R, Hashemipour M, Adeli K, Tavakoli N, Movahedian-Attar A, Shapouri J, et al. Effect of zinc supplementation on markers of insulin resistance, oxidative stress, and inflammation among prepubescent children with metabolic syndrome. Metab Syndr Relat Disord. 2010;8:505–10.PubMedCrossRef
64.
Ranasinghe P, Jayawardena R, Pigera A, Katulanda P, Constantine GR, Galappaththy P. Zinc supplementation in pre-diabetes: study protocol for a randomized controlled trial. Trials. 2013;14:52.PubMedPubMedCentralCrossRef
65.
Islam MR, Attia J, Ali L, McEvoy M, Selim S, Sibbritt D, et al. Zinc supplementation for improving glucose handling in pre-diabetes: a double blind randomized placebo controlled pilot study. Diabetes Res Clin Pract. 2016;115:39–46.PubMedCrossRef
66.
Chen L, Chen R, Wang H, Liang F. Mechanisms linking inflammation to insulin resistance. Int J Endocrinol. 2015;2015:9.
67.
Gelaye B, Revilla L, Lopez T, Suarez L, Sanchez SE, Hevner K, et al. Association between insulin resistance and c-reactive protein among Peruvian adults. Diabetol Metab Syndr. 2010;2:30.PubMedPubMedCentralCrossRef
68.
Preethi B, Kumar KP, Jaisri G, Suresh K. High-sensitivity C-reactive protein a surrogate marker of insulin resistance. J Physiol Pathophysiol. 2013;4:29–36.
69.
Yang JS, Gerber JN, You HJ. Association between fasting insulin and high-sensitivity C reactive protein in Korean adults. BMJ Open Sport ExerMed. 2017;3:e000236-e.CrossRef
70.
71.
Li L, Yang G, Li Q, Tang Y, Yang M, Yang H, et al. Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Exp Clin Endocrinol Diabetes. 2006;114:544–8.PubMedCrossRef
72.
Yue P, Jin H, Aillaud M, Deng AC, Azuma J, Asagami T, et al. Apelin is necessary for the maintenance of insulin sensitivity. Am J Physiol Endocrinol Metab. 2010;298:E59–67.PubMedCrossRef
73.
Assaad SN, El-Aghoury AA, El-Sharkawy EM, Azzam EZ, Salah MA. Study of serum apelin and its relation to obesity-associated hypertension. Egypt J Obes Diabetes Endocrinol. 2015;1:28.CrossRef
Metadata
Title
Zinc supplementation improves body weight management, inflammatory biomarkers and insulin resistance in individuals with obesity: a randomized, placebo-controlled, double-blind trial
Authors
Hoda Khorsandi
Omid Nikpayam
Reyhaneh Yousefi
Maryam Parandoosh
Nima Hosseinzadeh
Atoosa Saidpour
Arman Ghorbani
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2019
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/s13098-019-0497-8

Other articles of this Issue 1/2019

Diabetology & Metabolic Syndrome 1/2019 Go to the issue

Research

Glycemic variability is associated with vascular calcification by the markers of endoplasmic reticulum stress-related apoptosis, Wnt1, galectin-3 and BMP-2

Research

Stem cells from human exfoliated deciduous teeth ameliorate type II diabetic mellitus in Goto-Kakizaki rats

Research

Incidence and risk factors for metabolic syndrome among urban, adult Sri Lankans: a prospective, 7-year community cohort, follow-up study

Review

Diabetic nephropathy: recent advances in pathophysiology and challenges in dietary management

Research

Economic burden of diabetes in Brazil in 2014

Research

Interaction between ELMO1 gene polymorphisms and environment factors on susceptibility to diabetic nephropathy in Chinese Han population
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits